Visualitzacions | |
---|---|
Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the BEACON study | 75 |
gener 2024 | febrer 2024 | març 2024 | abril 2024 | maig 2024 | juny 2024 | juliol 2024 | |
---|---|---|---|---|---|---|---|
Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the BEACON study | 11 | 30 | 1 | 7 | 3 | 11 | 12 |
Visualitzacions | |
---|---|
artconlli_a2021_tabernero_josep_encorafenib_plus_cetuximab.pdf | 18 |
Visualitzacions | |
---|---|
Estats Units | 34 |
Xina | 7 |
Espanya | 5 |
Visualitzacions | |
---|---|
Menlo Park | 20 |
Barcelona | 5 |
Oakland | 5 |
Shanghai | 5 |
San Diego | 4 |
Jackson | 3 |
Fairfield | 1 |
Guangzhou | 1 |
Mountain View | 1 |
Xingtai | 1 |